Looking for a less risky way to find growth stocks amid all the artificial intelligence hype? The answer may lie overseas. Nicholas Anderson, a portfolio manager and managing director at Thornburg Investment Management, outlined a group of European stocks with the potential for faster earnings growth than that offered by the tech-focused " Magnificent 7 " stocks that have dominated the domestic market in the U.S.
, Anderson said, naming them as his favorites in the group. Europe's largest software company, Germany's SAP , is also fueling the group's earnings as it works to migrate customers to more profitable cloud subscriptions. Novo has a "first-mover advantage" in the market for GLP-1 diabetes and obesity drugs, Anderson said. Novo manufactures weight loss drug Wegovy and diabetes drug Ozempic, which have seen rampant demand.
said on Monday that it opened a test laboratory with Belgium chip research firm Imec for its High NA EUV lithography equipment, a first-of-its-kind $380 million system that can produce chips at nodes even smaller than two nanometers . One nanometer equals one billionth of a meter.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
ソース: CNBC - 🏆 12. / 72 続きを読む »
ソース: ForbesTech - 🏆 318. / 59 続きを読む »